Vigabatrin - sanofi-aventis
At a glance
- Drug Originator sanofi-aventis
- Drug Licenced by Alfresa Pharma Corporation; AstraZeneca; Lundbeck Inc
- Drug Class Aminobutyric acids; Antiepileptic drugs; Drug withdrawal therapies; Small molecules
- Mechanism of Action 4-aminobutyrate transaminase inhibitors
- USA Patent Applicants LUNDBECK PHARMS LLC
- NDAs 2
- Patent Applications 4,306
Table of Contents
Disclaimer